ストックスクリーナーアプリを入手
1.20
1.64%
-0.02
前日終値:
$1.22
開ける：
$1.22
24時間の取引高:
273.36K
Relative Volume:
0.74
時価総額：
$80.97M
収益：
-
当期純損益:
$-64.20M
株価収益率:
-0.5581
EPS:
-2.15
ネットキャッシュフロー:
$57,000
1週間 パフォーマンス:
-7.69%
1か月 パフォーマンス:
-17.24%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$1.20
$1.31
1週間の範囲:
$1.20
$1.3502
52週間の値動き範囲:
$1.20
$5.47
Climb Bio Inc Stock (CLYM) Company Profile
CLYM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CLYM
Climb Bio Inc
|
1.20 | 80.97M | 0 | -64.20M | 57,000 | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.74 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
617.00 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
567.09 | 34.59B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
255.76 | 33.10B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
271.04 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
Climb Bio Inc Stock (CLYM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-02 | 開始されました | Leerink Partners | Outperform |
Climb Bio Inc (CLYM) 最新ニュース
Climb Bio expands board with two new directors By Investing.com - Investing.com Australia
CLYM stock touches 52-week low at $1.2 amid market challenges - Investing.com India
Climb Bio appoints Kim Cobleigh Drapkin, Bo Cumbo to board - TipRanks
Climb Bio expands board with two new directors - Investing.com
Climb Bio Expands Board with New Director Appointments - TipRanks
Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors - The Manila Times
INmune Bio Inc. Presents Baseline Demographics and Disease Profiles of Participants in the MINDFuL Phase II Study - The Manila Times
Biotech Leaders Join Climb Bio Board: 11 Successful Drug Launches Experience - Stock Titan
What is Leerink Partnrs’ Estimate for Climb Bio Q2 Earnings? - Defense World
Bioplastics And Biopolymers Market Key Drivers, Opportunities and Trends | Exactitude Consultancy - Yahoo Finance
Climb Bio to Present at the 24th Annual Needham Virtual Healthcare Conference - The Manila Times
Healthcare Spotlight: Climb Bio Takes Center Stage at Major Needham Conference - Stock Titan
Climb Bio Advances Clinical Trials and Expands Pipeline - TipRanks
Can you use home equity to pay for long-term care? - Yahoo Finance
Climb Bio Fueled Up with Cash, Poised for More Milestones in ’25 – Quarterly Update Report - Yahoo Finance
Climb Bio Fueled Up with Cash, Poised for More Milestones in ’25 – Downloadable Quarterly Update - Yahoo Finance
Citigroup (C) Could Be a Great Choice - Yahoo Finance
China deals look beyond cancer - biocentury.com
Climb Bio Reports Fourth Quarter And Year-End 2024 Financial Results And Provides Business Updates - Marketscreener.com
Climb Bio Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Updates - Yahoo
Conagra to close Michigan plant, impacting 85 jobs - Yahoo Finance
Exclusive: BlackRock expands blockchain-based money market to Solana, in tie-up with startup Securitize - Yahoo Finance
Climb Bio Secures 3-Year Cash Runway with $212M, Advances Multi-Disease Pipeline - Stock Titan
Climb bio SVP Emily Pimblett sells shares worth $1,570 By Investing.com - Investing.com South Africa
Climb bio SVP Emily Pimblett sells shares worth $1,570 - Investing.com India
Why Are Jabil (JBL) Shares Soaring Today - Yahoo Finance
Climb Bio: Meet The Newest Star in Autoimmune Disease Treatment – Initiation Report - Yahoo Finance
Climb Bio (CLYM) Expected to Announce Earnings on Thursday - Defense World
Gossamer Bio shares rise on Q4 earnings beat By Investing.com - Investing.com South Africa
Gossamer Bio shares rise on Q4 earnings beat - Investing.com India
Bio-Key International Inc (BKYI): Major Improvements, Worth A Look - Stocks Register
Sugar Prices Climb on the Prospects for Lower Global Sugar Production - The Globe and Mail
Sugar Prices Climb on the Outlook for Small Sugar Output in India - The Globe and Mail
CLYM stock touches 52-week low at $1.29 amid market challenges - Investing.com Australia
CLYM stock touches 52-week low at $1.29 amid market challenges By Investing.com - Investing.com South Africa
(PDF) Research on Dynamics and Stability in the Stairs-Climbing of a Tracked Mobile Robot - ResearchGate
Stocks of Codexis Inc (CDXS) are poised to climb above their peers - SETE News
Mineralys shares climb on study data for blood pressure drug - BioPharma Dive
First-class stamp price climbs to £1.70 in ‘blow to consumers’ - Yahoo Finance UK
Global stocks climb as pound and euro hit four-month high against US dollar - Yahoo Finance UK
Climb Bio (NASDAQ:CLYM) Shares Down 6.9% – Should You Sell? - Defense World
FTSE 100 and US stocks climb higher as US inflation report meets expectations - Yahoo Finance UK
Stocks Climb Ahead Of Nvidia's Earnings Results - Barchart
Coupang’s shares climb after profit surges in competitive market - Fortune
CLYM stock touches 52-week low at $1.4 amid market challenges - Investing.com Australia
CLYM stock touches 52-week low at $1.4 amid market challenges By Investing.com - Investing.com South Africa
Plug To Announce 2024 Fourth Quarter and Year-End Results - The Manila Times
Climb Bio to Present at Upcoming Investor Conferences - The Bakersfield Californian
Climb Bio Sets Investor Calendar: Key March Presentations at Major Healthcare Conferences - StockTitan
After leaving FDA, Cavazzoni joins Pfizer as CMO - biocentury.com
Climb Bio appoints new Chief Business Officer By Investing.com - Investing.com Australia
Climb Bio Inc (CLYM) 財務データ
収益
当期純利益
現金流量
EPS
3.89%
0.13%
大文字化:
|
ボリューム (24 時間):